In vitro studies have demonstrated the dapagliflozin-mediated attenuation of TNF-α- and hyperglycemia-induced increases in ICAM-1, VCAM-1, PAI-1 and nuclear factor-kappa B (NFκB) expression [77]. The gene discussed is TNF; the disease is Hyperglycemia.